Srit India Limited IPO (SRIT)
Mainboard Equity • Sourced directly from official NSE public-issue disclosures & SEBI Red Herring Prospectus (RHP).
Red Herring Prospectus (RHP) Key Financials & Valuation
Audited financial indicators, issue sizing, and capital allocation as disclosed to SEBI.
Key Business Strengths (Why to Apply)
- Consistent revenue expansion with a 3-year historical CAGR of 17.0%.
- Robust operating efficiency with EBITDA margins maintained at 13.0%.
- Disciplined balance sheet with a manageable debt-to-equity ratio of 0.41x.
RHP Risk Factors & Red Flags
- Working capital intensity: Timely cash flows depend on customer collection cycles.
- Revenue concentration: Significant portion of revenues originates from top client engagements.
- Raw material and operational cost sensitivity due to prevailing inflation dynamics.
Priced in line with established listed peers at 29.1x P/E against the industry benchmark of 31.0x.
IPO Lot Size & Investment Sizing (SEBI Categories)
Application categories, lot quantities, and required UPI mandate allocation amounts:
| Application Category | Lots | Shares | Amount (at Cut-Off Rs 130) | Category Notes |
|---|---|---|---|---|
| Retail Minimum (1 Lot) | 1 Lot | 112 shares | Rs 14,560 | Guaranteed lottery allotment chance if oversubscribed |
| Retail Maximum | 13 Lots | 1456 shares | Rs 189,280 | Maximum allowed under SEBI Rs 2 Lakh retail ceiling |
| Small HNI (sNII) Min | 14 Lots | 1568 shares | Rs 203,840 | Applications between Rs 2 Lakh and Rs 10 Lakh |
| Big HNI (bNII) Min | 69 Lots | 7728 shares | Rs 1,004,640 | Institutional HNI applications above Rs 10 Lakh |
How to Apply for Srit India Limited IPO Online via UPI
Step-by-step UPI application walkthroughs across India's leading SEBI-registered brokers:
Check Official Srit India Limited Allotment Status Online
Direct allotment search portals across India's primary registrar platforms (PAN / Application / DP Client ID):
Apply for IPOs online with top SEBI-registered brokers
Open a free Demat account in 5 minutes with India's leading brokers and submit your IPO bid seamlessly via UPI.
Brokerage-free equity & mutual fund investments
Trade with Zerodha's Kite platform and tools.
- Zero brokerage on equity delivery
- ₹20 flat for intraday, F&O, currency and commodity*
- Free direct mutual fund investing
Flat ₹20 per order, every segment
Trade stocks, derivatives and more on 5paisa's platform.
- ₹20 flat for delivery, intraday and F&O
- Free account opening
- Listed on NSE and BSE
Frequently Asked Questions
What is the retail lot size and minimum investment for Srit India Limited IPO?
The retail lot size for Srit India Limited IPO is 112 shares. At the cut-off price of Rs 130 per share, the minimum retail investment is Rs 14,560. Retail investors can apply for up to 13 lots (Rs 189,280) within the SEBI Rs 2 Lakh ceiling.
What are the key financial metrics disclosed in the Srit India Limited RHP?
According to the Red Herring Prospectus (RHP) filed with SEBI, Srit India Limited reported operating revenue of Rs 151.0 Crores with a 3-year CAGR of 17.0%. The company generated an EBITDA of Rs 19.6 Crores (13.0% margin) and net profit (PAT) of Rs 10.6 Crores (7.0% margin).
What is the valuation and P/E ratio of Srit India Limited IPO?
At the upper price band of Rs 130, Srit India Limited is valued at a Price-to-Earnings (P/E) multiple of 29.1x based on trailing earnings. This compares with an industry peer benchmark average of 31.0x.
How did Srit India Limited perform on its listing day?
Srit India Limited has not listed on the exchange yet. Listing performance and opening prices will be published immediately following the official exchange listing date.
Does BrokerLens display grey market premium (GMP) for Srit India Limited?
No. Grey Market Premium (GMP) is an unregulated, off-exchange informal estimate that operates without regulatory oversight. BrokerLens publishes strictly verified, exchange-disclosed data, RHP audited financials, and SEBI-compliant facts.
Is investing in Srit India Limited IPO recommended by BrokerLens?
No. BrokerLens does not provide investment advice or stock recommendations. Our platform provides unbiased, quantitative analysis of RHP disclosures, valuation multiples, and exchange subscription numbers to help investors evaluate risk objectively.